Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. (Q46320460)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. |
scientific article |
Statements
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials (English)
Nashira Campos Vieira
Christine Herrenknecht
Joel Vacus
Alain Fournet
Christian Bories
Bruno Figadère
Philippe M Loiseau
25 September 2008